CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pharmacist-Led Medication Reviews: A Review of Clinical Utility and Cost-Effectiveness

Last updated: September 6, 2019
Project Number: RC1175-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary with Critical Appraisal
Result type: Report

Question

  1. What is the clinical utility of pharmacist-led medication reviews?
  2. What is the cost-effectiveness of pharmacist-led medication reviews versus no medication reviews?

Key Message

Evidence from four moderate- to high-quality systematic reviews suggests that pharmacist-led medicine reviews are associated with improvements in HbA1c and blood pressure control. However, the results may not be generalizable to the broader population.One economic evaluation was identified that suggested there was a net benefit to the Spanish national health system when pharmacists carried out medication review with follow-up among patients 65 years or older taking 5 or more medications. Differences in the healthcare delivery models and unit costs between Spain and Canada should be considered when generalizing results for the Canadian context.